Navigation Links
Single Shot of H1N1 Vaccine May Be Enough for Kids
Date:12/21/2009

But two doses still needed to ensure protection, experts say,,

MONDAY, Dec. 21 (HealthDay News) -- A single dose of the H1N1 flu vaccine may be enough to guard children and infants against potential infection, Australian researchers report.

Currently, the U.S. Centers for Disease Control and Prevention recommends that children and infants get two doses of the H1N1 vaccine, spaced about a month apart. This is the same recommendation the CDC has for seasonal flu vaccine, because usually a first dose is needed to prime the child's immune system for the second dose to create enough antibodies to be protective.

"It does appear that a single dose is to be very likely all that is required, even for babies," said lead researcher Dr. Terry Nolan, head of the Melbourne School of Population Health and Department of Public Health at the University of Melbourne.

This finding runs counter to the usual expectation that two doses are needed for children who have never been immunized against flu before, he said.

Giving a single dose to children may be most useful in vaccinating large populations. "It's logistically simpler, it's half the cost and for those unable to get the two doses, there are obvious advantages," he said.

This vaccine is likely to be highly protective against pandemic swine flu, Nolan added. "In addition, there is nothing to be concerned about in terms of safety or reaction rates to the vaccine."

The report is published in the Dec. 21 online edition of the Journal of the American Medical Association.

For the study, Nolan's team tested the effectiveness of the H1N1 flu vaccine in 370 infants and children aged 6 months to 9 years old. The children were randomly assigned to receive two injections of the vaccine, at either 15-microgram or 30-microgram doses.

These are higher doses than what is usually given, which is 7.5 micrograms, Nolan noted.

After the first dose, 92.5 percent of the children who received the 15-microgram dose and 97.7 percent of the children given the 30-microgram dose developed enough antibodies to the H1N1 swine flu to protect them from the virus.

The immune response was robust for all these children regardless of age, previous antibody status, or whether the child had received a seasonal flu shot, the researchers found.

Nolan noted that ongoing studies are testing whether one 7.5-microgram dose is enough to confer full protection from the H1N1 flu.

Based on the findings of this study and others, health officials around the world may want to reconsider the recommendation about the number of shots and doses children need to be protected, he said.

Dr. Anthony E. Fiore, a medical epidemiologist in the influenza division at the U.S. Centers for Disease Control and Prevention and co-author of an accompanying journal editorial, said that although the studied showed a good immune response to a single dose, "we would like to see additional studies."

Fiore noted that data from seasonal flu vaccine suggests that two doses are "the best choice for children under the age of 10. It's premature to go to the next step and say children only need one dose of the H1N1 vaccine," he said.

Parents should not rely on this study if their child received only one dose of the H1N1 flu vaccine, Fiore said.

"Don't relax based upon this study, thinking they don't need that second dose, because they really do to be certain and provide a level of an immune response that we are more confident is going to protect them," he said.

Infectious disease expert Dr. Marc Siegel, an associate professor of medicine at New York University in New York City, noted that last week's recall of children's H1N1 flu vaccine because it was not potent enough may be much ado about nothing.

Almost 800,000 children's doses of H1N1 swine flu vaccine were recalled by manufacturer Sanofi Pasteur Inc. because they had lost some potency, federal health officials said Tuesday.

"It goes to show you the hype about recalled children's pre-filled syringes and whether there is enough immunity may not really be a problem," he said. "Now there's this paper, which clearly shows that a single dose is enough to cause immunity in kids."

However, Siegel does not think the current two-dose protocol should be changed until there is more evidence to show that one dose is really effective.

"I don't think we should change the protocol. Two doses is ideal, but one is probably sufficient," he said.

More information

For more on the H1N1 flu, visit the Flu.gov.



SOURCES: Terry Nolan, M.B.B.S., Ph.D., professor and head, Melbourne School of Population Health, and Department of Public Health, University of Melbourne, Australia; Anthony E. Fiore, M.D., M.P.H., medical epidemiologist, influenza division, U.S. Centers for Disease Control and Prevention; Marc Siegel, M.D., associate professor, medicine, New York University, New York City; Dec. 21, 2009, Journal of the American Medical Association, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Julian Lennon and James Scott Cook Release New Charity Single LUCY to Raise Awareness and Funds for Lupus Research
2. Wayne State Researchers Report a Possible Proofreading Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase
3. East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program
4. Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
5. Texas Laparoscopic Consultants Profiled on ABC-13 TV as the Only Practice in Houston Offering Single-Incision, Quick Recovery Weight Loss Surgery
6. Ingenuity Systems Enhances Workflow for Experimental Transcriptome Analysis in Single Cells
7. New Squeezable Whole Fruit Sorbets in Single-Serve Tubes an Instant Hit
8. Mad As Hell Doctors to Hold Final "White Ribbon Rally" for Single Payer in Washington, D.C. on September 30th
9. Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
10. Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
11. Single Parents May Do as Well as Two: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... MD (PRWEB) , ... July 27, 2017 , ... ... Teams of entrepreneurs will compete to form startup companies around 117 breakthrough inventions ... Heart, Lung, and Blood Institute, and National Institute of Biomedical Imaging and Bioengineering), ...
(Date:7/27/2017)... ... July 27, 2017 , ... Cremations recently surpassed traditional burials ... Association, this trend is expected to continue with over 70% of Americans projected to ... demand for new innovations that enable families to celebrate the life of a lost ...
(Date:7/26/2017)... ... 2017 , ... An inventor from Salisbury, N.C., knows the difficulties involved with ... and dignified way to keep leeches in place during therapy," she said. "That’s why ... an effective way to keep a leech in place on the skin during therapy. ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: ... a major advancement in drug therapy for patients living with relapsing and primary ... a novel B cell targeted therapy that has been proven to significantly reduce ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... Management Solutions as part of their continued efforts to provide innovative offerings to ... the best IT resources and build dynamic, high-performing teams to address healthcare IT’s ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
(Date:7/13/2017)...  New York City-based market research firm Kalorama Information notes ... of.  From new products to new costs, to the threat ... completed study, Potential Pipeline Disruptors . Among ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... impact the growing population and, to a more extreme extent, ...
Breaking Medicine Technology: